Within the NHANES data, we focused on metals, PFAS, phthalate and PAH metabolites alongside clinically interpretable hepatic outcomes (AST, ALT, GGT, ALP, total bilirubin) and a composite steatosis indicator (FLI), which capture hepatocellular injury, cholestasis, and fatty liver risk [30]. The gene discussed is GPT; the disease is steatosis.